Prevalencia de Gérmenes multidrogo resistentes más frecuentes asociados a infección de pie diabético en el servicio de hospitalización del Hospital General Monte Sinaí durante el periodo enero 2022 a enero del 2024.

Abstract

Introduction: Diabetes mellitus is an entity composed of multiple metabolic disorders. Type 2 affects 90% of cases, with 537 million adults affected, equivalent to 10.5% of the world population, of whom 10-25% will develop diabetic foot with severe risks such as amputation and high health costs due to multidrug-resistant MDR infections. Objectives: to identify the prevalence of MDR germs associated with diabetic foot in Monte Sinai hospital Materials and methods: Observational, descriptive, cross-sectional and retrospective study carried out in a hospital in Guayaquil-Ecuador with a duration of 24 months between January 2022 and January 2024, obtaining data from clinical history forms of the hospital system. Results: The most frequent microorganism was K. pneumoniae 25 (17.7%) followed by E.coli 24 (17%). The resistance presented by these microorganisms was mainly due to extended spectrum beta-lactamases (BLEE) corresponding to 41.8% of the total studied. Conclusions: The prevalence of multidrug resistant germs associated with diabetic foot in patients of the hospitalization service of the Hospital General Monte Sinai during the study period consisted in order of frequency by K. pneumoniae, followed by E. coli, P. aeruginosa, P. mirabilis and M. morganii, with an evident predominance of Gram negative microorganisms being the most frequent mechanisms for the development of the same the presence of extended spectrum Betalactamases, followed by the production of Carbapenemases